• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » FDA labels IABP recall for Getinge’s Maquet, Datascope as Class I

FDA labels IABP recall for Getinge’s Maquet, Datascope as Class I

June 7, 2018 By Fink Densford

Maquet, Datascope

The FDA today labeled a select recall of Getinge‘s (PINK:GETI B) Datascope and Maquet Cardiosave hybrid intra-aortic balloon pumps over issues related to fluid seepage and corrosion as Class I.

A Class I recall is the federal watchdog’s most serious class of recall, indicating the potential for serious injury or death.

The Cardiosave hybrid intra-aortic balloon pump is designed for use as a cardiac assist device for use with patients undergoing cardiac and non-cardiac surgery, as well as to treat patients with acute coronary syndrome or complications from heart failure, the FDA wrote in its release.

The devices are being recalled over a design issue which could allow fluids to seep into the system which could result in corrosion of internal components including sensitive electronics. Such corrosion and seepage could cause delays or interruption in therapy, and could result in serious adverse health consequences, including death, according to the FDA.

The recall affects all lots of devices with part numbers 0998-00-0800-XX & 0998-UC-0800-XX and cart 0997-00-1179 , but excluding 0998-00-0800-83, 0998-UC-0800-83 & 0998-00-0800-75, manufactured between December 12, 2011 and April 25, 2018 and distributed between March 6, 2012 and April 26, 2018, according to the FDA posting.

Maquet instructed users to avoid placing fluids on top of the unit, ensure that saline containers and tubing do not hang over the device and, in case of accidental spillage, wipe the device clean immediately and have the unit serviced to avoid hazards.

If an interruption occurs, Maquet suggested users transfer patients to an alternative IABP. If an alternative is not available, the company suggested manual inflation of the IAB with air or helium and immediate aspiration, repeated every five minutes until either an alternate IABP is available or removal of the device.

Maquet said it will contact affected customers to resolve the issues, and that it expects to have a protective top cover for the devices available later this month.

Last June, the FDA released information on a select voluntary recall of Getinge’s Datascope and Maquet System CS100, CS100i and CS300 intra-aortic balloon pumps over issues with potential electrical test failures.

Filed Under: Cardiovascular, Food & Drug Administration (FDA), Recalls, Structural Heart Tagged With: Datascope Corp., Getinge, Maquet Cardiovascular LLC

More recent news

  • Sequel Med Tech’s automated twiist pump scores FDA clearance in type 2 diabetes
  • FDA posts alert for Edwards Lifesciences mitral valve delivery system after patient death
  • Former Medtronic RDN leader joins Teleflex
  • CMR Surgical CEO outlines the path forward for Stryker’s robotics partnership
  • Stryker earns FDA clearance for new bone and soft tissue removal platform

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy